StreetAlpha
13F holdings · Q2 2026

Enavate Sciences Gp

New York, NY · files as Enavate Sciences Gp, LLC
Holdings as of Jun 30, 2026Filed Aug 14, 2026Next filing due Nov 16, 2026CIK 1953107

Enavate Sciences Gp reported 7 stocks worth $345M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are SION (31.6%), ZBIO (28.8%) and IMNM (22.2%). Compared with Q1 2026, the fund trimmed CAMP.

Reported value$345M−1.7% vs last quarter
Stocks held70 new · 0 sold out
Top 5 weight93.3%very concentrated
Turnover1%of the portfolio changed
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 7 qtrsHeld
1
SION
Sionna Therapeutics Inc
$109M31.6%2.5MNo change6 of 7
2
ZBIO
Zenas Biopharma Inc
$99.5M28.8%3.9MNo change7 of 7
3
IMNM
Immunome Inc
$76.6M22.2%3.6MNo change7 of 7
4
BBOT
Bridgebio Oncology Therapeut
$20M5.8%2.6MNo change4 of 7
5
CMPX
Compass Therapeutics Inc
$17.1M4.9%7.8MNo change7 of 7
6
UPB
Upstream Bio Inc
$17M4.9%2.5MNo change7 of 7
7
CAMP
CAMP4 Therapeutics Corp
$6.2M1.8%1.4M−765K (−35%)7 of 7

Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.

Reported value

last 7 quarters
$139MQ4 '24
$133MQ1 '25
$177MQ2 '25
$328MQ3 '25
$507MQ4 '25
$352MQ1 '26
$345MQ2 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q2 2026

straight from the SEC
FiledFormQuarter
Aug 14, 202613F-HRQ2 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Enavate Sciences Gp 13F FAQ

What does Enavate Sciences Gp own?

Enavate Sciences Gp reported 7 stocks worth $345M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are SION (31.6%), ZBIO (28.8%) and IMNM (22.2%). The table above lists every position in the filing (the top 10 without an account).

What did Enavate Sciences Gp buy and sell in Q2 2026?

Compared with Q1 2026: 0 new positions, 0 added to, 1 trimmed and 0 sold out.

When will Enavate Sciences Gp file its next 13F?

Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.

How much is Enavate Sciences Gp's portfolio worth?

The Q2 2026 filing reports $345M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.